Expert guidance on clinical trials, mutations, and precision medicine
Everything you need to know about KRAS G12C mutations and the latest targeted therapy trials.
Common misconceptions that prevent patients from finding potentially life-saving treatments.
Why many oncologists don't discuss trials and how to start the conversation.
Breakthrough combination therapies and the trials you should know about.
Recent drug approvals and how they affect ongoing clinical trial enrollment.
One patient's journey from diagnosis to enrollment in a targeted therapy trial.
Get weekly updates on new trials, mutation research, and patient resources.
No spam. Unsubscribe anytime.